Key result
Among children hospitalized with infective endocarditis without congenital heart disease, S. aureus infection was associated with higher mortality than other organisms.
Observational (n=1,588)
Yes
Answers are grounded in this paper and cite their sources.
Source: Day MD, Gauvreau, G, Shulman, S, et al. Characteristics of children hospitalized with infective carditis. Circulation. 2009;119(6):865–870; doi:10.1161/CIRCULATIONA-HA.108.798751Investigators from Harvard and Northwestern medical schools used demographic, microbiologic, and outcomes data from the Healthcare Cost and Utilization Project Kids’ In-patient Database (KID) to study infective endocarditis (IE) in children. The KID consists of a stratified random sample of 2.5 million discharges from 2,784 institutions in 27 states in 2000 and 2.9 million discharges from 3,438 institutions in 36 states in 2003. Data from 2000 and 2003 for children younger than 21 years with hospital discharge diagnosis codes indicating IE were extracted.There were 1,588 patients with IE, half of whom were male. The median age was 12 years (range 1 day to 20 years). However, there was a bimodal age distribution with 34% of the patients under 1 year of age and 31% aged 17 to 20 years. Pre-existing heart disease was present in 41.7% of patients and was associated with significantly longer and more costly hospital stays and a tendency toward higher in-hospital mortality. Among patients without heart disease, the most commonly associated conditions were neoplasms (9.5%), prematurity (5.8%), connective tissue disorders (5.6%), and diabetes mellitus (2.4%).For the entire patient populations, the median length of stay (LOS) was 10 days and was similar for both years. Hospital charges were significantly higher in 2003 compared to 2000, $45,218 versus $31,313. Microbiologic etiology of IE was available for 632 (40%) of the admissions. Staphylococcus aureus was the most common organism (57%), followed by viridans streptococci (20%) and coagulase-negative staphylococcus (14%).The majority of the admissions were to teaching hospitals (78.3%). Compared to admissions to non-teaching hospitals, patients admitted to teaching hospitals were significantly younger (10 vs 16 years) and had longer median LOS (12 vs 5 days), higher median hospital costs ($48,535 vs $15,636), more pre-existing heart disease (46.1% vs 26.3%), and more cardiac surgeries performed on the same admission (10.0% vs 0.6%). Overall mortality was not significantly different between teaching and non-teaching hospitals (5.9% vs 3.6%).Tetralogy of Fallot was the most common congenital heart disease (CHD), occurring in 106 of 535 admissions (19.8%) with CHD codes. Although patients with pre-existing CHD were more likely to die (5.75 vs 5%; P=.09), the difference was not statistically significant. Among children without CHD, both prematurity (13.3% vs 4.5%) and S. aureus infection (93% vs 8.5% for all other organisms) were associated with higher mortality rates (93% vs 8.5%; P<.001).The authors conclude that there has been a shift toward a higher proportion of children developing IE without pre-existing cardiac disease. Risk factors for mortality with IE include pre-existing heart disease and, among those without underlying cardiac disease, prematurity and infection with S. aureus.Dr. Rathore has disclosed no financial relationship relevant to this commentary. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.This study updates our current understanding of the epidemiology of IE in childhood. IE, though rare, continues to be one of the major complications in children with CHD before and after surgical intervention. Increasingly, however, IE occurs in patients without pre-existing CHD. Almost 60% of the patients in this study had no evidence of pre-existing CHD compared to 26% of patients reported in 1992 and 8% of patients reported in 1972.1,2Several textbooks still report the viridans group of streptococci as the most important cause of IE in the pediatric age group.3,4 Recent clinical observations and single center smaller studies have suggested that S. aureus has become the most common pathogen causing IE.2 is study confirms not only that S. aureus is the most common cause of IE, but that infection with S. aureus was significantly more likely to result in death. Although not reported in this study, the increasing prevalence of community-associated methicillin-resistant S. aureus may make empiric antimicrobial therapy even more challenging. A recent international collaborative study also showed that S. aureus was the most common cause of endocarditis in adults.5The current study also demonstrated the bimodal age distribution of children with IE with almost one-third of the children 17 years of age or older, and almost 50% 12 years of age or older. Now that children with CHD are surviving longer, with an estimated one million adults with CHD living in the US in 20006 and increasing at a rate of 5% a year,7 it is not surprising that there are now more adults than children with CHD.8 It is very plausible that the age distribution of IE in childhood will shift further to the older age group. Many, if not most children with CHD will reach adulthood and will need care by an internist. This transition to adult care needs to occur in an orderly and deliberate manner if these children, already having survived great odds, are to have productive and healthy lives.IE is an uncommon, albeit apparently increasing disease with significant mortality (see AAP Grand Rounds, October 2008;20:44–459). In its 2007 revision of guidelines for the prevention of IE, the American Heart Association again endorsed the maxim of “an ounce of prevention,” but with a radically different emphasis on cardiac conditions with the “highest risk of adverse outcomes from IE,” rather than on routine pre-procedure antibiotic prophylaxis.10 These recommendations have garnered both confusion and controversy (see AAP Grand Rounds, February 2008;19:13–1410). The data generated by multi-institutional investigations such as the current study can only assist in the ascertainment of any changes in the etiology and epidemiology of IE post-adoption of the new guidelines.
No takes yet. Share an insight, caveat, or question.
A 2009 study conducted an observational in Infective endocarditis (n=1,588). S. aureus infection vs. Infection with all other organisms was evaluated on Mortality among children without congenital heart disease (p=<0.001). Among children hospitalized with infective endocarditis without congenital heart disease, S. aureus infection was associated with higher mortality than other organisms.
Synapse has enriched 10 related papers. Consider them for comparative context: